RadioMedix focuses on treatments for rare and aggressive cancers, specifically developing and advancing targeted alpha therapy and radiopharmaceuticals.
RadioMedix focuses on treatments for rare and aggressive cancers, specifically developing and advancing targeted alpha therapy and radiopharmaceuticals.
